Qhslab, INC. 8-K Filing
Ticker: USAQ · Form: 8-K · Filed: Nov 18, 2025 · CIK: 856984
Sentiment: neutral
Filing Stats: 1,128 words · 5 min read · ~4 pages · Grade level 11.3 · Accepted 2025-11-18 08:00:43
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Indicate by ch
- $1.4 million — cipal and accrued interest in excess of $1.4 million as of the date of redemption. Under t
- $300,000 — rchased the Notes for a cash payment of $300,000 (the "Repurchase Price"). The Repurchas
- $0.20 — s common stock at a conversion price of $0.20 per share. The foregoing description
Filing Documents
- form8-k.htm (8-K) — 47KB
- ex10-1.htm (EX-10.1) — 8KB
- ex99-1.htm (EX-99.1) — 15KB
- ex10-1_001.jpg (GRAPHIC) — 465KB
- ex10-1_002.jpg (GRAPHIC) — 501KB
- ex10-1_003.jpg (GRAPHIC) — 530KB
- ex10-1_004.jpg (GRAPHIC) — 406KB
- ex10-1_005.jpg (GRAPHIC) — 94KB
- ex10-1_006.jpg (GRAPHIC) — 23KB
- ex10-1_007.jpg (GRAPHIC) — 23KB
- ex99-1_001.jpg (GRAPHIC) — 24KB
- 0001493152-25-023990.txt ( ) — 3085KB
- usaq-20251118.xsd (EX-101.SCH) — 3KB
- usaq-20251118_lab.xml (EX-101.LAB) — 33KB
- usaq-20251118_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
Dilution
Dilution 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 18, 2025 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman